Inovio Pharmaceuticals, Inc. (INO)

Inovio Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	21.69	14.31	46.33	71.14	250.73	22.2
Short-Term Investments	63.12	130.98	206.67	330.17	160.91	67.34
Cash & Short-Term Investments	84.8	145.29	253	401.31	411.64	89.53
Cash Growth	-49.36%	-42.57%	-36.96%	-2.51%	359.76%	10.22%
Receivables	1.86	2.41	11.74	8.03	19.06	2.03
Prepaid Expenses	4.62	5.41	20.51	39.1	4.8	2.63
Other Current Assets	-	-	30	-	35.66	-
Total Current Assets	91.28	153.11	315.24	448.44	471.17	94.2
Property, Plant & Equipment	12.56	14.45	17.96	29.02	24.09	26.56
Long-Term Investments	2.64	2.78	2.01	3.91	4.89	6.32
Goodwill	-	-	10.51	10.51	10.51	10.51
Other Intangible Assets	-	-	2.13	2.63	3.15	3.69
Other Long-Term Assets	0.57	0.61	0.68	1.43	25.96	2.67
Total Assets	107.06	170.95	348.53	495.94	539.77	143.95
Accounts Payable	5.39	4.65	21.08	27.97	1.47	7.65
Accrued Expenses	15.69	18.64	26.42	30.55	30.08	15.09
Current Portion of Long-Term Debt	-	16.77	-	-	-	-
Current Portion of Leases	2.43	2.41	2.8	2.6	2.33	2.07
Current Unearned Revenue	-	0.11	2.56	4.62	7.58	6.9
Other Current Liabilities	-	-	44	-	0.25	0.27
Total Current Liabilities	23.5	42.57	96.87	65.74	41.71	31.99
Long-Term Debt	-	-	16.61	14.96	18.66	77.02
Long-Term Leases	10.02	11.03	12.66	15.46	18.06	20.41
Long-Term Unearned Revenue	-	-	-	0.06	0.12	0.24
Long-Term Deferred Tax Liabilities	-	-	0.03	0.03	0.03	0.03
Other Long-Term Liabilities	-	-	-	0.01	0.06	8.86
Total Liabilities	33.52	53.6	126.17	96.27	78.63	138.55
Common Stock	0.03	0.02	0.02	0.22	0.19	0.1
Additional Paid-In Capital	1,785	1,741	1,711	1,610	1,367	742.65
Retained Earnings	-1,711	-1,623	-1,488	-1,210	-906.2	-739.79
Comprehensive Income & Other	-0.62	-0.66	-0.7	-0.28	-0.26	0.47
Total Common Equity	73.54	117.35	222.36	399.67	461.14	3.44
Minority Interest	-	-	-	-	-	1.97
Shareholders' Equity	73.54	117.35	222.36	399.67	461.14	5.4
Total Liabilities & Equity	107.06	170.95	348.53	495.94	539.77	143.95
Total Debt	12.45	30.21	32.07	33.02	39.05	99.51
Net Cash (Debt)	72.36	115.08	220.92	368.29	372.59	-9.97
Net Cash Growth	-47.44%	-47.91%	-40.01%	-1.15%	-	-
Net Cash Per Share	2.85	5.19	11.11	21.16	28.82	-1.21
Filing Date Shares Outstanding	26.1	23.37	21.68	18.12	17.3	12.15
Total Common Shares Outstanding	26.05	22.79	21.09	18.12	15.57	8.45
Working Capital	67.79	110.54	218.37	382.7	429.46	62.21
Book Value Per Share	2.82	5.15	10.54	22.06	29.62	0.41
Tangible Book Value	73.54	117.35	209.72	386.53	447.48	-10.77
Tangible Book Value Per Share	2.82	5.15	9.94	21.34	28.74	-1.28
Machinery	-	9.9	13.49	20.59	12.16	10.93
Leasehold Improvements	-	15.92	15.8	15.8	15.18	15.01

Source: S&P Capital IQ. Standard template. Financial Sources.